<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 5 Issue 2</issue_number>
<issue_period>2014 (April - June)</issue_period>
<title>MICRO-DETERMINATION OF TADALAFIL IN PHARMACEUTICAL FORMULATIONS AND URINE SAMPLES OF DIABETIC PATIENTS TYPE-II IN TAIF AREA, SAUDIA ARABIA USING ATOMIC ABSORPTION AND ATOMIC EMISSION SPECTROMETRY </title>
<abstract>New ion – associate complexes of tadalafil hydrochloride with [ Cadmium (II) and Zinc (II)] thiocyanates were precipitated and the excess unreacted metal complex was determined. A new method was given for the determination of tadalafil drug in pure solutions, in pharmaceutical formulations and urine samples of diabetic patients type – II using atomic emission and atomic absorption spectrometry. The drug can be determined by the affort method in the range 0.32 - 160.65 μg mL lessThan sup greaterThan -1 lessThan /sup greaterThan .</abstract>
<authors>SABRY KH. MOHAMED, YOUSRI M. HUSSEIN  AND BASSEM M. RAAFAT</authors>
<keywords>Atomic emission, atomic absorption, ion-associate complexes, pharmaceutical analysis.</keywords>
<pages>285-291</pages>
</article>
</Journal>
